EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Exploring the pivotal role of hot melt extrusion technology in developing PLGA based novel drug delivery platforms for better therapeutic outcomes

Mashan Almutairi, Reem Hammad Almuhwes, Joud Abdulkarim Alshammari, Haneen Fahad Alsleem, Ghala Naif Algharbi, Yazed S Alsowaida, Sultan Almuntashiri, Ahmed Alobaida

Saudi Pharmaceutical Journal · 2026-06 · 34 (3)

DOI: 10.1007/s44446-026-00096-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Saudi Pharmaceutical Journal, online erschienen am 29.06.2026. Verfasst von Mashan Almutairi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, University of Ha'il, 81442, Ha'il, Saudi Arabia. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Scientific Research Deanship at University of Ha'il, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among various biodegradable polymers, polylactic-co-glycolic acid (PLGA) is one of most widely studied synthetic polymer for controlled and targeted drug delivery. PLGA is a smart polymer as it has stimuli-responsive behaviour. PLGA is approved by the US FDA for multiple therapeutic applications due to its biodegradability, biocompatibility and sustained-release behaviour. PLGA is commercially available as different molecular weights and copolymer ratios, which allow for tuning polymer behaviour to suit numerous applications. Different methods have been used to process PLGA into diverse morphologies, structures and sizes. Traditional PLGA processing methods face many limitations related to scalability and residual solvents. This review was limited to the emerging hot melt extrusion (HME), a more specific, solvent-free and highly scalable technology for fabricating PLGA-based formulations. Key operational parameters such as glass transition temperature, melt viscosity, and degradation behaviour are discussed alongside with the drug-related stability, dispersion and final solid-state properties that need several factors to be fine-tuned to offer a performance with optimal efficiency. This tunability of characteristics makes PLGA driven by HME ideal for fabrication with advanced manufacturing technologies to deliver surprisingly novel drug delivery platforms that can boost therapeutic efficacy and patient compliance across a range of clinical fields.

Schlagwörter

Stichwörter der Autor:innen

BiocompatibleBiodegradableControlled releaseHot melt extrusionPLGA

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, University of Ha'il, 81442, Ha'il, Saudi Arabia.
  • Department of Clinical Pharmacy, College of Pharmacy, University of Ha'il, 81442, Ha'il, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, University of Ha'il, 81442, Ha'il, Saudi Arabia. a.alobaida@uoh.edu.sa.

Förderung

  • Scientific Research Deanship at University of Ha'il, Saudi Arabia

Zitieren

APA

Almutairi, M., Almuhwes, R. H., Alshammari, J. A., Alsleem, H. F., Algharbi, G. N., Alsowaida, Y. S., Almuntashiri, S., & Alobaida, A. (2026). Exploring the pivotal role of hot melt extrusion technology in developing PLGA based novel drug delivery platforms for better therapeutic outcomes. Saudi Pharmaceutical Journal, 34(3). https://doi.org/10.1007/s44446-026-00096-w

Vancouver

Almutairi M, Almuhwes RH, Alshammari JA, Alsleem HF, Algharbi GN, Alsowaida YS, et al. Exploring the pivotal role of hot melt extrusion technology in developing PLGA based novel drug delivery platforms for better therapeutic outcomes. Saudi Pharmaceutical Journal. 2026;34(3). doi:10.1007/s44446-026-00096-w

BibTeX
@article{Almutairi2026,
  author = {Almutairi, Mashan and Almuhwes, Reem Hammad and Alshammari, Joud Abdulkarim and Alsleem, Haneen Fahad and Algharbi, Ghala Naif and Alsowaida, Yazed S and Almuntashiri, Sultan and Alobaida, Ahmed},
  title = {Exploring the pivotal role of hot melt extrusion technology in developing PLGA based novel drug delivery platforms for better therapeutic outcomes},
  journal = {Saudi Pharmaceutical Journal},
  year = {2026},
  volume = {34},
  number = {3},
  doi = {10.1007/s44446-026-00096-w}
}
Kostenlos starten →